Miromatrix Medical Inc. (MIRO) News
Filter MIRO News Items
MIRO News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
MIRO News Highlights
- For MIRO, its 30 day story count is now at 2.
- Over the past 1 day, the trend for MIRO's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
- MD and UTHR are the most mentioned tickers in articles about MIRO.
Latest MIRO News From Around the Web
Below are the latest news stories about MIROMATRIX MEDICAL INC that investors may wish to consider to help them evaluate MIRO as an investment opportunity.
United Therapeutics and Miromatrix Medical Announce Completion of Tender Offer and MergerSILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C. & EDEN PRAIRIE, Minn., December 13, 2023--United Therapeutics Corporation (Nasdaq: UTHR) and Miromatrix Medical Inc. (Nasdaq: MIRO) announced today that United Therapeutics, through its wholly owned subsidiary Morpheus Subsidiary Inc. ("Merger Sub"), has successfully completed the previously announced tender offer to acquire all outstanding shares of Miromatrix for a purchase price of $3.25 per share in cash at closing and an additional $1.75 per |
United Therapeutics and Miromatrix Medical Announce Successful Tender OfferSILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C. & EDEN PRAIRIE, Minn., December 12, 2023--United Therapeutics Corporation (Nasdaq: UTHR) and Miromatrix Medical Inc. (Nasdaq: MIRO) announced today the results of the previously announced tender offer by Morpheus Subsidiary Inc. ("Merger Sub"), a wholly owned subsidiary of United Therapeutics, to acquire all outstanding shares of Miromatrix for a purchase price of $3.25 per share in cash at closing and an additional $1.75 per share in cash upon t |
Miromatrix Reports Third Quarter 2023 ResultsEDEN PRAIRIE, Minn., Nov. 14, 2023 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (Nasdaq: MIRO) (the “Company”), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients' lives, today reported third quarter 2023 financial results. Due to the Company’s pending proposed transaction with United Therapeutics Corporation (Nasdaq: UTHR) (“United Therapeutics”), the Company’s management has suspended guidance for 2023 and will |
Six Flags' pact with Cedar Fair; Disney's Hulu buy: 4 big deal reportsHere is your Pro Recap of 4 head-turning deal dispatches you may have missed last week: Disney to buy the remaining stake in Hulu from Comcast's NBCUniversal, and deals at Six Flags Entertainment/Cedar Fair, Realty Income/Spirit Realty Capital, and United Therapeutics/Miromatrix Medical. On Thursday, in line with recent speculation, the amusement park companies Cedar Fair (NYSE:FUN) and Six Flags Entertainment (NYSE:SIX) disclosed their agreement to merge in an all-stock transaction. Upon completion of the merger, Cedar Fair's unitholders will hold a majority stake of 51.2%, while Six Flags' shareholders will possess around 48.8% in the newly formed entity, which is projected to have a pro forma enterprise value close to $8 billion. |
Why Is Conduit Pharmaceuticals (CDT) Stock Up 66% Today?Conduit Pharmaceuticals stock is rising higher on Monday with heavy trading of CDT shares despite a lack of news from the company. |
Why Is Miromatrix Medical (MIRO) Stock Up 235% Today?Miromatrix Medical stock is rocketing higher on Monday after the company reached an acquisition agreement with United Therapeutics for MIRO. |
Why Is Nuvve (NVVE) Stock Down 11% Today?Nuvve stock is falling on Monday despite recent insider buying but the price of purchase of NVVE shares may be behind today's drop. |
Why Is Medicenna Therapeutics (MDNA) Stock Down Today?Medicenna Therapeutics stock is falling on Monday after the company announced that shares of MDNA will be delisted from the Nasdaq. |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on MondayIt's time to dive into the biggest pre-market stock movers as we start the trading week on Monday with the hottest coverage! |
United Therapeutics to Acquire Miromatrix MedicalSILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C. and EDEN PRAIRIE, Minn., Oct. 30, 2023 (GLOBE NEWSWIRE) -- United Therapeutics Corporation (Nasdaq: UTHR) and Miromatrix Medical Inc. (Nasdaq: MIRO) announced today a definitive agreement for United Therapeutics to acquire Miromatrix. Miromatrix is a life sciences company focused on the development of bioengineered organs composed of human cells. United Therapeutics is a biotechnology company with six FDA-approved therapies to address rare, lif |